CA2492661C - Elaboration non stochastique de vaccins genetiques et d'enzymes - Google Patents

Elaboration non stochastique de vaccins genetiques et d'enzymes Download PDF

Info

Publication number
CA2492661C
CA2492661C CA2492661A CA2492661A CA2492661C CA 2492661 C CA2492661 C CA 2492661C CA 2492661 A CA2492661 A CA 2492661A CA 2492661 A CA2492661 A CA 2492661A CA 2492661 C CA2492661 C CA 2492661C
Authority
CA
Canada
Prior art keywords
nucleic acid
sequences
polynucleotide
sequence
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2492661A
Other languages
English (en)
Other versions
CA2492661A1 (fr
Inventor
Jay M. Short
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BP Corp North America Inc
Original Assignee
BP Corp North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/246,178 external-priority patent/US6171820B1/en
Application filed by BP Corp North America Inc filed Critical BP Corp North America Inc
Publication of CA2492661A1 publication Critical patent/CA2492661A1/fr
Application granted granted Critical
Publication of CA2492661C publication Critical patent/CA2492661C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2492661A 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes Expired - Fee Related CA2492661C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/246,178 US6171820B1 (en) 1995-12-07 1999-02-04 Saturation mutagenesis in directed evolution
US09/246,178 1999-02-04
CA002325351A CA2325351C (fr) 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002325351A Division CA2325351C (fr) 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes

Publications (2)

Publication Number Publication Date
CA2492661A1 CA2492661A1 (fr) 2000-08-10
CA2492661C true CA2492661C (fr) 2014-11-18

Family

ID=34575108

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2492661A Expired - Fee Related CA2492661C (fr) 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes

Country Status (1)

Country Link
CA (1) CA2492661C (fr)

Also Published As

Publication number Publication date
CA2492661A1 (fr) 2000-08-10

Similar Documents

Publication Publication Date Title
CA2325351C (fr) Elaboration non stochastique de vaccins genetiques et d'enzymes
US6479258B1 (en) Non-stochastic generation of genetic vaccines
US6713279B1 (en) Non-stochastic generation of genetic vaccines and enzymes
US20110165627A1 (en) Gene site saturation mutagenesis
US20240263354A1 (en) Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
EP2397549A2 (fr) Génération non stochastique de vaccins génétiques et enzymes
US20030219752A1 (en) Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
WO2002092780A2 (fr) Nouvelles molecules de liaison a un antigene destinees a des applications therapeutiques, diagnostiques, prophylactiques, enzymatiques, industrielles et agricoles et procedes de generation et de criblage de telles molecules
CA2320626A1 (fr) Vecteurs de vaccins mis au point par genie genetique
US20010006950A1 (en) Genetic vaccine vector engineering
US20080019988A1 (en) Targeting of genetic vaccine vectors
CA2268265A1 (fr) Procedes permettant l'optimisation de la therapie genique grace a un rearrangement et une selection recursifs de sequences
EP3435087A1 (fr) Nouveaux procédés d'évolution protéique
CA2492661C (fr) Elaboration non stochastique de vaccins genetiques et d'enzymes
EP3092491B1 (fr) Orthologues ciblant les protéines
AU2005201125B2 (en) Non-stochastic generation of genetic vaccines and enzymes
AU2005333666A1 (en) Delivery of active proteins to the central nervous system using phage vectors
AU2002318140A1 (en) Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
IL138206A (en) Methods for non-stochastic generation of progeny polypeptides and hybrid polynucleotides
AU2757902A (en) Genetic vaccine vector engineering
AU2767702A (en) Targeting of genetic vaccine vectors

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180205